OMEROS CORP Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
OMEROS CORP (OMER) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 17.49 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 17.49M shares, a 63.04% increase year-over-year.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 18.20M shares, a 96.90% increase year-over-year.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 12.77M shares, a 133.40% increase year-over-year.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 10.73M shares, a 9.50% increase year-over-year.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 12.81M shares, a 55.54% increase from fiscal 2024.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 8.23M shares, a 46.85% decline from fiscal 2023.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 15.49M shares, a 10.06% decline from fiscal 2022.
- OMEROS CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 17.22M shares, a 8.51% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.49M shares 10-Q · filed 2026-08-12 | 17.86M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 18.20M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 12.81M shares 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | 12.77M shares 10-Q · filed 2025-11-13 | 9.06M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 10.73M shares 10-Q · filed 2026-08-12 | 10.32M shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 9.24M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 8.23M shares 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | 5.47M shares 10-Q · filed 2025-11-13 | 8.99M shares 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 9.80M shares 10-Q · filed 2025-08-14 | 10.79M shares 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | 11.78M shares 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | 15.49M shares 10-K · filed 2026-03-31 | |||||||
| 2023-09-30 | 17.22M shares 10-Q · filed 2024-11-13 | 17.22M shares 10-Q · filed 2023-11-09 | 17.22M shares 10-Q · filed 2024-11-13 | 17.22M shares 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | 17.30M shares 10-Q · filed 2024-08-07 | 17.25M shares 10-Q · filed 2024-08-07 | ||||||
| 2023-03-31 | 17.22M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 17.22M shares 10-K · filed 2025-03-31 | |||||||
| 2022-09-30 | 17.33M shares 10-Q · filed 2023-11-09 | 5.16M shares 10-Q · filed 2022-11-09 | 17.32M shares 10-Q · filed 2023-11-09 | 5.16M shares 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | 17.32M shares 10-Q · filed 2023-08-09 | 5.15M shares 10-Q · filed 2022-08-09 | 17.32M shares 10-Q · filed 2023-08-09 | 5.15M shares 10-Q · filed 2022-08-09 | ||||
| 2022-03-31 | 17.34M shares 10-Q · filed 2023-05-09 | 5.03M shares 10-Q · filed 2022-05-10 | ||||||
| 2021-12-31 | 18.82M shares 10-K · filed 2024-04-01 | 6.65M shares 10-K · filed 2022-03-01 | ||||||
| 2021-09-30 | 6.72M shares 10-Q · filed 2022-11-09 | 1.78M shares 10-Q · filed 2021-11-09 | 7.45M shares 10-Q · filed 2022-11-09 | 2.50M shares 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | 7.34M shares 10-Q · filed 2022-08-09 | 2.40M shares 10-Q · filed 2021-08-09 | 7.84M shares 10-Q · filed 2022-08-09 | 2.90M shares 10-Q · filed 2021-08-09 | ||||
| 2021-03-31 | 8.39M shares 10-Q · filed 2022-05-10 | 3.45M shares 10-Q · filed 2021-05-10 | ||||||
| 2020-12-31 | 15.61M shares 10-K · filed 2023-03-13 | 1.60M shares 10-K · filed 2021-03-01 | ||||||
| 2020-09-30 | 1.47M shares 10-Q · filed 2021-11-09 | 1.79M shares 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | 2.23M shares 10-Q · filed 2021-08-09 | 1.95M shares 10-Q · filed 2021-08-09 | 13.03M shares 10-Q · filed 2020-08-10 | |||||
| 2020-03-31 | 1.67M shares 10-Q · filed 2021-05-10 | 12.83M shares 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | 13.60M shares 10-K · filed 2022-03-01 | 11.45M shares 10-K · filed 2020-03-02 | ||||||
| 2019-09-30 | 3.04M shares 10-Q · filed 2020-11-09 | 11.74M shares 10-Q · filed 2019-11-12 | 2.85M shares 10-Q · filed 2020-11-09 | 11.74M shares 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 12.04M shares 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 12.08M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 2.87M shares 10-K · filed 2021-03-01 | 10.56M shares 10-K · filed 2019-03-01 | ||||||
| 2018-09-30 | 10.37M shares 10-Q · filed 2019-11-12 | 10.37M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 10.84M shares 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 9.74M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 9.76M shares 10-K · filed 2020-03-02 | |||||||
| 2017-09-30 | 9.91M shares 10-Q · filed 2018-11-08 | |||||||
| 2017-06-30 | 10.44M shares 10-Q · filed 2018-08-09 | |||||||
| 2017-03-31 | 11.02M shares 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | 9.91M shares 10-K · filed 2019-03-01 | |||||||
| 2016-09-30 | 9.44M shares 10-Q · filed 2017-11-09 | |||||||
| 2016-06-30 | 9.60M shares 10-Q · filed 2017-08-08 | |||||||
| 2016-03-31 | 9.30M shares 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | 9.06M shares 10-K · filed 2018-03-01 | |||||||
| 2015-09-30 | 9.51M shares 10-Q · filed 2015-11-09 | 9.51M shares 10-Q · filed 2016-11-09 | ||||||
| 2015-06-30 | 9.58M shares 10-Q · filed 2016-08-09 | |||||||
| 2015-03-31 | 9.53M shares 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | 8.92M shares 10-K · filed 2017-03-16 | |||||||
| 2014-09-30 | 7.38M shares 10-Q · filed 2015-11-09 | 7.38M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 7.42M shares 10-Q · filed 2015-08-10 | |||||||
| 2014-03-31 | 7.37M shares 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | 7.58M shares 10-K · filed 2016-03-15 | |||||||
| 2013-09-30 | 7.52M shares 10-Q · filed 2014-11-10 | |||||||
| 2013-06-30 | 5.92M shares 10-Q · filed 2014-08-11 | |||||||
| 2013-03-31 | 5.97M shares 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | 5.88M shares 10-K · filed 2015-03-16 | |||||||
| 2012-09-30 | 4.73M shares 10-Q · filed 2013-11-07 | |||||||
| 2012-06-30 | 4.74M shares 10-Q · filed 2013-08-09 | |||||||
| 2012-03-31 | 4.78M shares 10-Q · filed 2013-05-09 | |||||||
| 2011-12-31 | 3.62M shares 10-K · filed 2014-03-13 | |||||||
| 2011-09-30 | 3.78M shares 10-Q · filed 2012-11-09 | |||||||
| 2011-06-30 | 3.93M shares 10-Q · filed 2012-08-07 | |||||||
| 2010-12-31 | 4.20M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |